Heparin dosing and monitoring for cardiopulmonary bypass
Authors:
- Glenn P. GravleeGGGlenn P. Gravlee
- W. Scott HaddonWHW. Scott Haddon
- Henry K. RothbergerHRHenry K. Rothberger
- Stephen A. MillsSMStephen A. Mills
- Anne T. RogersARAnne T. Rogers
- Virgil E. BeanVBVirgil E. Bean
- David H. BussDBDavid H. Buss
- Donald S. ProughDPDonald S. Prough
- A. Robert CordellACA. Robert Cordell
- 1 March 1990
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 99 (3) , 518-527
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Early Anticoagulation Peak and Rapid Distribution After Intravenous HeparinAnesthesiology, 1988
- Hemostasis Changes During Cardiopulmonary Bypass SurgerySeminars in Thrombosis and Hemostasis, 1985
- Biochemical and Pharmacologic Studies on the Protamine Interactions with Heparin, Its Fractions and FragmentsSeminars in Thrombosis and Hemostasis, 1985
- Heparin, Its Fractions, Fragments and Derivatives Some Newer PerspectivesSeminars in Thrombosis and Hemostasis, 1985
- Performance Characteristics of a Simple Radioimmunoassay for Fibrinopeptide ASeminars in Thrombosis and Hemostasis, 1984
- Heparin Monitoring and Neutralization during Cardiopulmonary Bypass Using a Rapid Plasma Separator and a Fluorometric AssayThe Annals of Thoracic Surgery, 1984
- Monitoring Heparin Anticoagulation and Its NeutralizationThe Annals of Thoracic Surgery, 1981
- Lack of Correlation Between Activated Clotting Time and Plasma Heparin During Cardiopulmonary BypassAnnals of Surgery, 1981
- Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass.Circulation, 1980
- Measurement of Fibrinopeptide A in Human BloodJournal of Clinical Investigation, 1974